Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking

• Hauptverfasser: Armstrong David (VerfasserIn), Prevost A Toby (VerfasserIn), Hollands Gareth J (VerfasserIn), Sanderson Jeremy (VerfasserIn), Watts Sally (VerfasserIn), Forbes Alastair (VerfasserIn), Lewis Cathryn M (VerfasserIn), Mathew Christopher G (VerfasserIn), Whitwell Sophia CL (VerfasserIn), Kinmonth Ann (VerfasserIn), Sutton Stephen (VerfasserIn), Marteau Theresa M (VerfasserIn)
• Format: Buch
• Veröffentlicht: BMC, 2011-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Estimates of the risk of developing Crohn's disease (CD) can be made using DNA testing for mutations in the NOD2 (CARD15) gene, family history, and smoking status. Smoking doubles the risk of CD, a risk that is reduced by stoppi...